FIELD: biology, medicine, nanotechnology.
SUBSTANCE: group of inventions is referred to the area of biology, medicine, nanotechnology and involves processing of new platform carriers for formation of complexes with biologically active compounds. The proposed platform carriers are of spherical shape and are made by the way of thermal reconfiguration of structure of tobacco mosaic virus (TMV) or another tobamovirus or another plant virus with spiral structure or their fragments. The platform carriers are also produced by the way of thermal reconfiguration of coat protein of TMV group virus (tobamoviruses) or another phytovirus with spiral structure or their fragments. There were also proposed the compositions containing the platform-carrier of said spherical carrier connected with the alien protein or another biologically active compound. The advantages of new platform carriers include the simplicity and quickness of production, possibility to get spherical particles of regulated sizes, long term storage, absence of aggregation and preservation of spherical shape during its storage, centrifugation and resedimentation, the convenience of spherical particles shape for formation of complexes with target compound.
EFFECT: important feature of a new carrier platform is the capability to adsorb on the surface and to form compositions with different structurally and functionally alien proteins/antigens.
3 cl, 6 ex, 10 dwg
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC COMPOSITION, CONTAINING FOREIGN ANTIGENS ON SURFACE OF SPHERICAL CARRIERS, OBTAINED BY THERMAL DENATURATION OF SPIRAL VIRUSES | 2010 |
|
RU2440140C1 |
THE METHOD OF IMMUNE RESPONSE ENHANCEMENT | 2010 |
|
RU2442604C1 |
RUBELLA VACCINE ON THE BASIS OF A STRUCTURALLY-MODIFIED VIRUS OF PLANTS AND A METHOD FOR ITS PRODUCTION | 2016 |
|
RU2660563C2 |
VIRIONS AND VIRUS-LIKE PARTICLES OF ALTERNANTHERA MOSAIC VIRUS AS AMPLIFIERS OF IMMUNE RESPONSE | 2015 |
|
RU2639491C2 |
METHOD OF PREPARING BIOLOGICALLY ACTIVE COMPLEX | 2009 |
|
RU2427386C1 |
ANTIGEN FOR RECOMBINANT VACCINE AGAINST RUBELLA VIRUS | 2019 |
|
RU2709328C1 |
VACCINE PREPARATION | 2009 |
|
RU2409386C1 |
BIOLOGICALLY ACTIVE COMPLEX EXHIBITING INFLUENZA VIRUS PROTECTIVE ACTIVITY | 2009 |
|
RU2427385C1 |
PLANT VIRUS RECOMBINANT ANTHRAX VACCINE | 2023 |
|
RU2821917C1 |
METHOD OF PRODUCING PREPARATIVE QUANTITIES OF PHLOEM-RESTRICTED VIRAL ANTIGENS | 2012 |
|
RU2525136C1 |
Authors
Dates
2012-02-10—Published
2010-12-09—Filed